BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 1896402)

  • 1. Changes in rheology and red blood cell function under recombinant human erythropoietin therapy.
    Schmidt R; Lerche D; Dörp E; Winkler R; Klinkmann H
    Pol Arch Med Wewn; 1991 Jun; 85(6):384-90. PubMed ID: 1896402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative injury to erythrocytes, cell rigidity and splenic hemolysis in hemodialyzed patients before and during erythropoietin treatment.
    Zachée P; Ferrant A; Daelemans R; Coolen L; Goossens W; Lins RL; Couttenye M; De Broe ME; Boogaerts MA
    Nephron; 1993; 65(2):288-93. PubMed ID: 8247195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired erythrocyte fluidity during treatment of renal anaemia with erythropoietin.
    Linde T; Sandhagen B; Danielson BG; Wikström B
    J Intern Med; 1992 Jun; 231(6):601-6. PubMed ID: 1619383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Improvement of hemorheologic parameters in hemodialyzed patients treated with human recombinant erythropoietin].
    Delamaire M; Durand F; Hamel D; Joyeux V; Lepogamp P; Genetet B
    J Mal Vasc; 1991; 16(3):289-94. PubMed ID: 1940657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rheological studies during treatment of renal anaemia with recombinant human erythropoietin.
    Macdougall IC; Davies ME; Hutton RD; Coles GA; Williams JD
    Br J Haematol; 1991 Apr; 77(4):550-8. PubMed ID: 2025581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Red cell membrane during erythropoietin therapy in hemodialysis and in hemodiafiltration.
    Icardi A; Paoletti E; Traverso GB; Sarchi C; Cappelli G; Molinelli G
    Int J Artif Organs; 1991 Mar; 14(3):147-9. PubMed ID: 2045188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood rheology in hemodialysis patients treated with recombinant human erythropoietin.
    Brunner R; Pollok M; Heidel M; Müller R; Degenhardt S; Baldamus CA
    Contrib Nephrol; 1989; 76():306-12; discussion 312-4. PubMed ID: 2582784
    [No Abstract]   [Full Text] [Related]  

  • 8. Red blood cell deformability is very slightly decreased in erythropoietin deficient mice.
    Pichon A; Lamarre Y; Voituron N; Marchant D; Vilar J; Richalet JP; Connes P
    Clin Hemorheol Microcirc; 2014; 56(1):41-6. PubMed ID: 23302595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of renal anaemia with recombinant human erythropoietin results in decreased red cell uptake of 45Ca.
    Linde T; Ronquist G; Sandhagen B; Wikström B; Frithz G; Pettersson L; Danielson BG
    Nephron; 1994; 68(4):419-26. PubMed ID: 7870225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Human recombinant erythropoietin (rH-EPO) in chronic hemodialysis patients].
    Jalil R; Vaccarezza A; Jara A; Lira P; Vial S; Serrano V
    Rev Med Chil; 1990 Jun; 118(6):629-34. PubMed ID: 1775783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Erythropoietin-beta in the treatment of anemia in patients with chronic renal insufficiency].
    Dimković N
    Med Pregl; 2001; 54(5-6):235-40. PubMed ID: 11759218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rheology in whole blood and in red blood cells under recombinant human erythropoietin therapy.
    Lerche D; Schmidt R; Zoellner K; Meier W; Paulitschke M; Distler B; Klinkmann H
    Contrib Nephrol; 1989; 76():299-303; discussion 304-5. PubMed ID: 2684529
    [No Abstract]   [Full Text] [Related]  

  • 13. Recombinant human erythropoietin in predialysis patients.
    Lim VS
    Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):34-7. PubMed ID: 1928077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyporesponsiveness to recombinant human erythropoietin.
    Drüeke T
    Nephrol Dial Transplant; 2001; 16 Suppl 7():25-8. PubMed ID: 11590253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Subcutaneous administration of recombinant human erythropoietin (R-EPO) in the treatment of anemia in predialysis patients with chronic renal failure].
    Debska-Slizień A; Rutkowski B; Niemierko J; Jankowska-Gan E; Gołebiewska-Zurkowska G; Kabata J; Manitius A
    Pol Arch Med Wewn; 1991 Jun; 85(6):334-40. PubMed ID: 1896396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of erythropoiesis under the influence of recombinant human erythropoietin (R-EPO) in dialyzed patients].
    Debska-Slizień A; Kabata J; Rutkowski B; Ciesielski D; Jankowska-Gan E; Manitius A
    Pol Arch Med Wewn; 1991 Jun; 85(6):341-51. PubMed ID: 1896397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recombinant human erythropoietin stimulates synthesis of fetal hemoglobin in patients with renal anemia treated by repeated hemodialysis].
    Hanicki Z; Sułowicz W; Stepniewski M; Kuźniewski M; Kraśniak A; Kopeć J; Cieszkowska U; Solarska K
    Pol Arch Med Wewn; 1991 Jun; 85(6):352-5. PubMed ID: 1716757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of erythropoietin in children with terminal renal insufficiency treated with chronic hemodialysis].
    Peco-Antić A; Popović-Rolović M; Jovanović O; Kostić M; Kruscić D
    Srp Arh Celok Lek; 1992; 120(5-6):147-52. PubMed ID: 1465668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring erythropoietin therapy for anaemia of chronic renal failure by serum erythropoietin assays.
    Marsden JT; Sherwood RA; Hillis A; Peters TJ
    Ann Clin Biochem; 1993 Mar; 30 ( Pt 2)():205-6. PubMed ID: 8466156
    [No Abstract]   [Full Text] [Related]  

  • 20. [Activity of selected neutrophil enzymes of patients maintained on hemodialysis and treated with erythropoietin (rHu EPO)].
    Sułowicz W; Hanicki Z; Lisiewicz J; Kopeć A; Kraśniak A; Kuźniewski M; Kopeć J; Sydor A
    Pol Arch Med Wewn; 1991 Jun; 85(6):391-5. PubMed ID: 1896403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.